GMAT Question of the Day: Daily via email | Daily via Instagram New to GMAT Club? Watch this Video

 It is currently 26 Jan 2020, 16:27

### GMAT Club Daily Prep

#### Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.

Customized
for You

we will pick new questions that match your level based on your Timer History

Track

every week, we’ll send you an estimated GMAT score based on your performance

Practice
Pays

we will pick new questions that match your level based on your Timer History

# Although the new cochleae manufactured by Medotech will cost more than

Author Message
TAGS:

### Hide Tags

Math Expert
Joined: 02 Sep 2009
Posts: 60646
Although the new cochleae manufactured by Medotech will cost more than  [#permalink]

### Show Tags

28 Oct 2019, 21:23
00:00

Difficulty:

5% (low)

Question Stats:

85% (01:47) correct 15% (02:05) wrong based on 86 sessions

### HideShow timer Statistics

Competition Mode Question

Although the new cochleae manufactured by Medotech will cost more than twice as much as the cochlear implants now in use, Medotech implants should still be cost-effective. Not only will surgery and recovery time be reduced, but Medotech cochlear replacements should last longer, thereby reducing the need for further hospital stays.

Which of the following must be studied in order to evaluate the argument presented above?

A. The amount of time a patient spends in surgery versus the amount of time spent recovering from surgery.
B. The amount by which the cost of producing Medotech cochlear replacements has declined with the introduction of the new technique for producing them.
C. The degree to which the use of Medotech cochlear replacements is likely to reduce the need for repeat surgery when compared with the use of the replacements now in use.
D. The degree to which the use of Medotech replacements are more carefully manufactured than are the replacements now in use,
E. The amount by which Medotech will drop in cost as the production procedures become standardized and applicable on a larger scale.

_________________
Senior Manager
Joined: 01 Mar 2019
Posts: 404
Location: India
Concentration: Strategy, Social Entrepreneurship
Schools: Ross '22, ISB '20, NUS '20
GPA: 4
Re: Although the new cochleae manufactured by Medotech will cost more than  [#permalink]

### Show Tags

29 Oct 2019, 03:30
2
C. The degree to which the use of Medotech cochlear replacements is likely to reduce the need for repeat surgery when compared with the use of the replacements now in use.....This helps in evaluating how it is cost effective though it's of twice the cost....

OA:C

Posted from my mobile device
Manager
Joined: 23 Nov 2018
Posts: 246
GMAT 1: 650 Q49 V28
GPA: 4
Re: Although the new cochleae manufactured by Medotech will cost more than  [#permalink]

### Show Tags

28 Oct 2019, 22:54
1
Although the new cochleae manufactured by Medotech will cost more than twice as much as the cochlear implants now in use, Medotech implants should still be cost-effective. Not only will surgery and recovery time be reduced, but Medotech cochlear replacements should last longer, thereby reducing the need for further hospital stays.

conclusion: Medotech implants should still be cost-effective

reasoning: Medotech cochlear replacements last longer= reducing further hospital stays= cost effective
hospitals stays are more expensive that the cost difference between the two different implants

possible underlying assumptions:
1) Hospital stays are expensive, and no other factors other than hospital stays influence expenses for the patients wrt Medotech implants
2) present Cochlear implants are not more cost effective in other ways to compensate more than required for the hospital visits as compared to Medotech implants
3) hospital stay costs are way more than the difference in the purchase cost between the two kinds of impants

with this reasoning in mind lets attack the options:

A. The amount of time a patient spends in surgery versus the amount of time spent recovering from surgery.
the amount spent in surgery is completely irrelevant to the argument, it can be more or less or the same for the two implants, therefore this option is irrelevant

B. The amount by which the cost of producing Medotech cochlear replacements has declined with the introduction of the new technique for producing them.
how is production cost relevant with cost savings wrt hospital stays? this is way out of scope with the argument and our initial reasoning

C. The degree to which the use of Medotech cochlear replacements is likely to reduce the need for repeat surgery when compared with the use of the replacements now in use.

This is the correct answer!! as the need for another surgery is reduced so are the costs wrt the hospital stays after the surgery!

D. The degree to which the use of Medotech replacements are more carefully manufactured than are the replacements now in use,

the replacements could still be better or good enough even if they are not as carefully manufactured

E. The amount by which Medotech will drop in cost as the production procedures become standardized and applicable on a larger scale.

suppose Medotech drops the cost by 1% then it is still more expensive and this option still doesnt provide us with a reason as to how Medotech is still more cost effective despite being expensive

C is the correct option!
_________________
Manager
Joined: 30 Nov 2017
Posts: 57
GMAT 1: 690 Q49 V35
Re: Although the new cochleae manufactured by Medotech will cost more than  [#permalink]

### Show Tags

29 Oct 2019, 00:09
1
IMO: C

Conclusion: Although New Cochleae manufactured by Medotech cost more but are cost effective because:
1) It will reduce surgery and recovery time
2) It will last longer than the regular cochleae

Which of the following must be studied in order to evaluate the argument presented above?

A. The amount of time a patient spends in surgery versus the amount of time spent recovering from surgery. Comparing the time spent on surgery to recovery won't make any difference to the conclusion.

B. The amount by which the cost of producing Medotech cochlear replacements has declined with the introduction of the new technique for producing them. There is no mention of new technique

C. The degree to which the use of Medotech cochlear replacements is likely to reduce the need for repeat surgery when compared with the use of the replacements now in use. This is important if the need for repeat surgery is not reduced than the cost impact of the new device will be higher and hence undesirable.

D. The degree to which the use of Medotech replacements are more carefully manufactured than are the replacements now in use. this will have no impact on the conclusion

E. The amount by which Medotech will drop in cost as the production procedures become standardized and applicable on a larger scale. this will have no impact on the conclusion
GMAT Club Legend
Joined: 18 Aug 2017
Posts: 5734
Location: India
Concentration: Sustainability, Marketing
GPA: 4
WE: Marketing (Energy and Utilities)
Re: Although the new cochleae manufactured by Medotech will cost more than  [#permalink]

### Show Tags

29 Oct 2019, 08:21
1
Conclusion;Not only will surgery and recovery time be reduced, but Medotech cochlear replacements should last longer, thereby reducing the need for further hospital stays.

Option C
The degree to which the use of Medotech cochlear replacements is likely to reduce the need for repeat surgery when compared with the use of the replacements now in use
use variance test
IMO C both strengthens and weakens the argument

Although the new cochleae manufactured by Medotech will cost more than twice as much as the cochlear implants now in use, Medotech implants should still be cost-effective. Not only will surgery and recovery time be reduced, but Medotech cochlear replacements should last longer, thereby reducing the need for further hospital stays.

Which of the following must be studied in order to evaluate the argument presented above?

A. The amount of time a patient spends in surgery versus the amount of time spent recovering from surgery.
B. The amount by which the cost of producing Medotech cochlear replacements has declined with the introduction of the new technique for producing them.
C. The degree to which the use of Medotech cochlear replacements is likely to reduce the need for repeat surgery when compared with the use of the replacements now in use.
D. The degree to which the use of Medotech replacements are more carefully manufactured than are the replacements now in use,
E. The amount by which Medotech will drop in cost as the production procedures become standardized and applicable on a larger scale.
Manager
Joined: 17 Mar 2019
Posts: 131
Re: Although the new cochleae manufactured by Medotech will cost more than  [#permalink]

### Show Tags

29 Oct 2019, 10:37
1
Although the new cochleae manufactured by Medotech will cost more than twice as much as the cochlear implants now in use, Medotech implants should still be cost-effective. Not only will surgery and recovery time be reduced, but Medotech cochlear replacements should last longer, thereby reducing the need for further hospital stays.

Stimulus: Medotech implants will cost more but are still cost effective. They reduce the surgery and recovery time but should last longer reducing the need for further hospital stays. Inorder to evaluate the problem we need to know if by the use of new implants last longer than the old implants so that though they are expensive they are still cost effective.

Which of the following must be studied in order to evaluate the argument presented above?

A. The amount of time a patient spends in surgery versus the amount of time spent recovering from surgery.
B. The amount by which the cost of producing Medotech cochlear replacements has declined with the introduction of the new technique for producing them.
C. The degree to which the use of Medotech cochlear replacements is likely to reduce the need for repeat surgery when compared with the use of the replacements now in use. Correct this makes the cochlear replacements effective.
D. The degree to which the use of Medotech replacements are more carefully manufactured than are the replacements now in use,
E. The amount by which Medotech will drop in cost as the production procedures become standardized and applicable on a larger scale.

IMO C.
Senior Manager
Joined: 11 Feb 2013
Posts: 266
Location: United States (TX)
GMAT 1: 490 Q44 V15
GMAT 2: 690 Q47 V38
GPA: 3.05
WE: Analyst (Commercial Banking)
Re: Although the new cochleae manufactured by Medotech will cost more than  [#permalink]

### Show Tags

29 Oct 2019, 20:21
1
I would go for C.

A. Since Medotech cochlear replacement is reducing both surgery and recovery time, they can not be evaluating factors.
B. Cost of production is irrelevant to cost effectiveness assessment of patients
D. Being careful in production process is irrelevant to cost effectiveness assessment of patients
E. Reducing costs in production process is irrelevant to cost effectiveness assessment of patients.
Senior Manager
Joined: 11 Feb 2013
Posts: 266
Location: United States (TX)
GMAT 1: 490 Q44 V15
GMAT 2: 690 Q47 V38
GPA: 3.05
WE: Analyst (Commercial Banking)
Re: Although the new cochleae manufactured by Medotech will cost more than  [#permalink]

### Show Tags

29 Oct 2019, 20:23
1
C.

If probability of repeat surgery increases with Medotech cochlear replacement, cost for the patients will be DOUBLE for surgery. So, Medotech cochlear replacement will not be cost effective.

If probability of repeat surgery decreases with Medotech cochlear replacement, Medotech cochlear replacement will be cost effective because of less time staying in hospital.
Director
Joined: 18 May 2019
Posts: 665
Re: Although the new cochleae manufactured by Medotech will cost more than  [#permalink]

### Show Tags

28 Oct 2019, 23:14
Cost of new cochleae > 2 * cost of existing cochleae.
Yet new cochleae still cost-effective because surgery and recovery times will reduce, and new cochleae will last longer, leading to fewer hospital stays.

The emphasis here is cost-effectiveness. The best answer choice must be one that relates to the benefits of the new cochleae in terms of cost.

The choice is between options C and option E.

Option C: The degree to which the use of Medotech cochlear replacements is likely to reduce the need for repeat surgery when compared with the use of the replacements now in use.

Option E: The amount by which Medotech will drop in cost as the production procedures become standardized and applicable on a larger scale.

Between C and E, only E relates to cost. Merely knowing the degree to which the use of the new cochleae replacements is likely to reduce the need for repeat surgery is not enough to determine cost effectiveness. We need to find a way to associate cost with the reduction in repeat surgery associated with the new cochleae. So, option C is inferior compared with option E. This is because option E provides the amount by which Medotech will drop in cost as the production procedures become standardized and applicable on a larger scale. Option E talks about cost savings when the new cochleae is adopted, and if such a piece of information is available, then it will be very useful to evaluate the argument.

The answer in my view is option E.
Math Expert
Joined: 02 Sep 2009
Posts: 60646
Re: Although the new cochleae manufactured by Medotech will cost more than  [#permalink]

### Show Tags

29 Oct 2019, 20:56
Bunuel wrote:

Competition Mode Question

Although the new cochleae manufactured by Medotech will cost more than twice as much as the cochlear implants now in use, Medotech implants should still be cost-effective. Not only will surgery and recovery time be reduced, but Medotech cochlear replacements should last longer, thereby reducing the need for further hospital stays.

Which of the following must be studied in order to evaluate the argument presented above?

A. The amount of time a patient spends in surgery versus the amount of time spent recovering from surgery.
B. The amount by which the cost of producing Medotech cochlear replacements has declined with the introduction of the new technique for producing them.
C. The degree to which the use of Medotech cochlear replacements is likely to reduce the need for repeat surgery when compared with the use of the replacements now in use.
D. The degree to which the use of Medotech replacements are more carefully manufactured than are the replacements now in use,
E. The amount by which Medotech will drop in cost as the production procedures become standardized and applicable on a larger scale.

Official Explanation

The best answer is C. To evaluate the argument it must be determined whether these savings will compensate for the increased cost. Therefore, study of the expected reduction in the need for further hospital stays is needed.
_________________
Re: Although the new cochleae manufactured by Medotech will cost more than   [#permalink] 29 Oct 2019, 20:56
Display posts from previous: Sort by